top of page


January 15, 2016

Roche and Catalent team up in $600m conjugation tech deal


January 7, 2016

Principia Biopharma Advances BTK Inhibitor Program in Autoimmune Disease and FGFR Inhibitor Program in Oncology


January 7, 2016

4D Molecular Therapeutics Announces Collaboration With Pfizer Inc. for Cardiac Gene Therapy Vector Discovery and Development


January 7, 2016

Circle Pharma Announces Receipt of Additional Seed Investment, Relocation to New Laboratory Facility and Initiation of Internal Pipeline Development


January 6, 2016

eFFECTOR Therapeutics Initiates Dosing in Phase 1/2 Clinical Trial of eFT508 in Solid Tumors


December 22, 2015

eFFECTOR Therapeutics Raises $40 Million Series B Financing


November 4, 2015

Gates Foundation, GSK, others back biotech in white-hot area of cancer


November 4, 2015

Atreca, Inc., Completes Oversubscribed $56 Million Series A Funding to Advance Pipeline of Novel Cancer Immunotherapies


June 16, 2015

Zymergen Grabs $44M For “Designer” Microbes Tested by Robots


June 3, 2015

A Bay Area Startup Spins Lab-Grown Silk


May 12, 2015

Bay Area Fund, Aligned With UC, Raises New Cash To Seed Biotechs


May 12, 2015

Small but mighty VC doubles up with new biotech seed fund


October 3, 2014

Catalent Expands Its Technology Offerings In Biologics, Acquires Redwood Bioscience Inc. And The SMARTag™ Technology Platform


April 29, 2014

Bristol-Myers Squibb Acquires iPierian, Inc.


October 29, 2013

Calithera BioSciences Nabs $35M for Cancer Drugs


May 21, 2013

Effector Therapeutics Raises $45M to Prove New Concept in Cancer


May 15, 2013

Bayer inks startup matchmaking deal with QB3, Mission Bay Capital


April 10, 2013

Catalent Biologics Expands Into ADCs Through Exclusive License With Redwood Bioscience


March 19, 2013

This Protein Could Change Biotech Forever


October 30, 2012

UCSF Spinout Principia Biopharma Thinking Big and Covalent


October 2, 2012

Startup Atreca Joins With Gates Foundation to Speed Vaccine Discovery


April 5, 2012

Mission Bay Capital Seeds Surgical Device Start-Up Magnamosis


September 8, 2011

Biopharma Venture Funds Are Stepping Up Where VC Firms Are Stepping Out


December 21, 2010

Expansion of Incubator Network, Seed Fund Among QB3 Priorities for 2011


September 16, 2010

New Venture Capital Firms In A Shrinking Industry (Part II)


July 7, 2010

Calithera, a UCSF Spinoff, Raises $40M to Develop Cancer Drugs


July 7, 2010

Mission Bay Capital invests in UCSF cancer therapy spinoff


April 26, 2010

Mission Bay Capital makes first investment, in UC biotech spinoff


April 25, 2010

UC targeted seed fund backs first startup


October 26, 2009

Mission Bay Capital Announces First Venture Fund


bottom of page